| Adverse Drug Reaction due to Cancer Chemotherapy and its Financial Burden in Different Hospitals of Nepal SS Sunil Shrestha, Rajani Shakya, Sudip Shrestha International Journal of Pharmacovigilance 2 (1), 7, 2017 | 23* | 2017 |
| Medication Adherence: Fact or Fictions? AK Mohiuddin International Journal of Pharmacovigilance 6 (1), 3, 2022 | 11 | 2022 |
| Corporate Paint and ancient pharmaceutical mixtures from Teotihuacan. The Teopancazco Neighborhood Center MLV de Agredos Pascual, LR Manzanilla International Journal of Pharmacovigilance 1 (1), 1-11, 2016 | 10 | 2016 |
| The Expression of the Human Cathelicidin LL-37 in the Human Dental Pulp: An In Vivo Study BF Sarmiento, A Aminoshariae, M Bakkar, T Bonfield, S Ghosh, ... International Journal of Pharmacovigilance 1 (1), 1-5, 2016 | 6 | 2016 |
| Pharmacovigilance: An Overview S Nimesh, VD Ashwlayan International Journal of Pharmacovigilance 3 (1), 1-6, 2018 | 5 | 2018 |
| Chemical and Therapeutic Aspects of Kefir KT M-Guedes, KT Magalhães International Journal of Pharmacovigilance 1 (2), 1-3, 2016 | 5* | 2016 |
| High-Dose Intravenous Vitamin C and Thiamine as Adjunct Therapy for Septic Shock in the Pediatric ICU: A Case Report RO Ana Almeda, Brigetta Martinez International Journal of Pharmacovigilance 3 (2), 1-5, 2018 | 3 | 2018 |
| A Descriptive Cross-Sectional Study Exploring Perceptions and Attitude of Pharmacists towards Adverse Drug Reporting in Pakistan AH Madeeha Malik, Aneela Amin International Journal of Pharmacovigilance 3 (2), 1-7, 2018 | 2 | 2018 |
| Macula Erythematous Rash Due to Temozolomide Involving Head and Neck Region Only S Shrestha, S Shrestha, BR Ghimire, S Shakya, G Prasiko, B Sapkota International Journal of Pharmacovigilance 3 (1), 1-2, 2018 | 2 | 2018 |
| Analyse of Polypharmacy and its Consequences on Nutritional Status in Elderly People Living in Nursing Home in Auvergne D Marie-Laure, L Bruno, B Anne, M Aurélien International Journal of Pharmacovigilance 3 (1), 1-8, 2018 | 1 | 2018 |
| An Innovative Risk Assessment Tool for Prospective Risk Analysis to Improve the Quality in Health Care: The Bow-Tie H Shoman, S Ellahham International Journal of Pharmacovigilance 3 (1), 1-3, 2018 | 1 | 2018 |
| Therapeutic anticoagulation prevalence among patients of a cardiology clinic receiving warfarin and association with overweight M Gossell-Williams International Journal of Pharmacovigilance 1 (1), 1- 4, 2016 | 1 | 2016 |
| Tracking of Additional Risk Minimization Measures (aRMM)-An Ardent Patient-Centric Activity for a Successful Risk Management Program HO 1*Brinda Soni, 2Dr. Jay Dave International Journal of Pharmacovigilance 7 (1), 5, 2023 | | 2023 |
| Pharmacovigilance and Drug Safety Considerations of Loperamide as an increasing drug of abuse: a report of 3 cases and an analysis of the FDA FAERS database from 2002-2022 SC Raj Masih, 2Barbra Masih, 3Kaylin Arbaugh, Janaina Rodrigues Dos Santos ... International Journal of Pharmacovigilance 6 (1), 9, 2022 | | 2022 |
| New view of Pharmacovigilance: towards real data and digital monitoring VT Hanna Pavliuk-Gavrylova1*,Oleksandr Torhun2 International Journal of Pharmacovigilance 5 (1), 5, 2021 | | 2021 |
| Meta-Analysis of the Effectiveness and Recanalization of Warfarin Combined With Low Molecular Weight Heparin in the Treatment of Intracranial Venous Sinus Thrombosis XX Xiaorui Ma1, Shasha Fang2 International Journal of Pharmacovigilance 5 (1), 7, 2021 | | 2021 |
| Dapsone-Induced Fulminant Hepatic Failure and Death of a Young Male MJHR Rabbani2 International Journal of Pharmacovigilance 4 (1), 3, 2020 | | 2020 |
| A Targeted Pharmacovigilance Study on Antitubercular Drugs in the Department of Pulmonary Medicine at Tertiary Care Teaching Hospital in Rural Area PPK Saurabh Nimesh1* International Journal of Pharmacovigilance 4 (1), 5, 2019 | | 2019 |
| Book Review ‘Allergies and Health Problems’ U Iqbal International Journal of Pharmacovigilance 3 (2), 1-1, 2018 | | 2018 |
| A Botanical Nano Ozonated Relax Oil Composition for Headache, Migraine, Autism and Depression AM Awad Mansour International Journal of Pharmacovigilance 3 (2), 1-4, 2018 | | 2018 |
